Walmart announced on Tuesday that it will soon start selling private-brand analog insulin that it says will save customers up to 75 percent off the cash price of branded versions of the drug and will “revolutionize” access and affordability of diabetes care. The big-box retailer will sell the product, marketed as ReliOn NovoLog Insulin, to adults and children with a prescription at Walmart pharmacies this week, and at Sam’s Club pharmacies in mid-July, the company said in a release. Walmart said it expects the new product will save customers between 58 and 75 percent off the cash price of branded products, which it said works out to as much as $101 in savings per branded vial and $251 per package of branded FlexPens. “We know many people with diabetes struggle to manage the financial burden of this condition, and we are focused on helping by providing affordable solutions,” said Dr. …
Originally found on the Epoch Times Read More
